Researchers are reporting two promising approaches to counteract malaria's growing drug resistance. Switzerland-based ...
The Lundquist Institute (TLI) and its start-up company Vitalex Biosciences (Vitalex) are pleased to announce that the second-generation fungal vaccine candidate known as VXV--01, which was developed ...
Doctors say the return of this disease reflects the brutal realities of modern trench combat and the struggle to evacuate the ...